Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

UMBRALISIB vs UMECLIDINIUM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

UMBRALISIB vs UMECLIDINIUM: Safety Overview

Metric UMBRALISIB UMECLIDINIUM
Total FAERS Reports 293 6,321
Deaths Reported 30 506
Death Rate 10.2% 8.0%
Hospitalizations 97 1,761
Average Patient Age 69.0 yrs 68.9 yrs
% Female Patients 43.8% 53.7%
FDA Approval Date Feb 5, 2021 Apr 30, 2014
Manufacturer N/A GlaxoSmithKline LLC
Route N/A RESPIRATORY (INHALATION)
Marketing Status Discontinued Prescription